Projects per year
Personal profile
Biography
Professor Peter Fuller is currently Head of the Centre for Endocrinology and Metabolism at the Hudson Institute (formerly Prince Henry’s Institute of Medical Research) and Head of the Endocrinology Unit at Monash Health. He is a physician-scientist whose clinical and research training was in Melbourne followed by postdoctoral training at the Massachusetts General Hospital. His research interests lie primarily in understanding the molecular mechanisms of adrenocortical steroid hormone action. His group also studies the molecular pathogenesis of endocrine tumours. He has served on principle committees/boards of the Endocrine Society (USA), NHMRC, Cancer Council of Victoria, Victorian Cancer Agency, Cabrini Institute and Endocrine Society of Australia. He has received awards from the Welcome Trust, the Royal Australasian College of Physicians and the British Endocrine Society and the Endocrine Society of Australia. In 2015 he was made a Member (AM) in the General Division of the Order of Australia.
http://hudson.org.au/researcher-profile/peter-fuller/
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
External positions
Director, Endocrinology Unit, Monash Health
Research area keywords
- Endocrinology
Collaborations and top research areas from the last five years
-
The CONSEP trial: Implementing screening for a hidden cause of hypertension
Yang, J. (Primary Chief Investigator (PCI)), Russell, G. (Chief Investigator (CI)), Stocks, N. P. (Chief Investigator (CI)), Nelson, M. R. (Chief Investigator (CI)), Skouteris, H. (Chief Investigator (CI)), Gwini, S. M. (Chief Investigator (CI)), Chen, G. (Chief Investigator (CI)), Reid, C. M. (Chief Investigator (CI)), Stowasser, M. (Chief Investigator (CI)), Fuller, P. (Chief Investigator (CI)), Melder, A. (Chief Investigator (CI)), Malios, J. (Associate Investigator (AI)), Wyatt, D. (Associate Investigator (AI)), Sikaris, K. (Associate Investigator (AI)), Burgess, J. R. (Associate Investigator (AI)) & Torpy, D. J. (Associate Investigator (AI))
1/02/23 → 30/04/28
Project: Research
-
EQUIPping Tertiary Care for the Optimal Diagnosis of Primary Aldosteronism
Yang, J. (Primary Chief Investigator (PCI)), Fuller, P. (Chief Investigator (CI)), Stowasse, M. (Chief Investigator (CI)), Glendenning, P. (Chief Investigator (CI)), Lu, Z. X. (Chief Investigator (CI)), Chong, W. (Chief Investigator (CI)), Horvath, A. R. (Chief Investigator (CI)), Endre, Z. (Chief Investigator (CI)), Thuzar, M. (Chief Investigator (CI)), Shen, J. (Chief Investigator (CI)), Jong, I. (Chief Investigator (CI)), Leenaerts, M. (Associate Investigator (AI)), Gwini, S. (Associate Investigator (AI)), Chen, G. (Associate Investigator (AI)), Skouteris, H. (Associate Investigator (AI)) & Morris, H. (Associate Investigator (AI))
Department of Health and Aged Care (Australia)
14/04/22 → 7/09/25
Project: Research
-
Advancing Ovarian Granulosa Cell Tumor Treatment: Structural Insights and Drug Discovery for the FOXL2C134W Mutation
Chu, S. (Primary Chief Investigator (PCI)), Wong, W. (Chief Investigator (CI)), Fuller, P. (Chief Investigator (CI)), Jobling, T. (Associate Investigator (AI)), Rosenbluh, S. (Associate Investigator (AI)) & Silke, J. (Associate Investigator (AI))
1/07/25 → 30/06/28
Project: Research
-
The MPCCC Precision Medicine Scholarship
Chu, S. (Primary Chief Investigator (PCI)) & Fuller, P. (Chief Investigator (CI))
6/12/21 → 16/12/24
Project: Research
-
Precision Medicine for hypertension: Early detection of primary aldosteronism
Yang, J. (Primary Chief Investigator (PCI)), Fuller, P. (Chief Investigator (CI)), Young, M. (Chief Investigator (CI)), Stowasser, M. (Chief Investigator (CI)), Russell, G. (Chief Investigator (CI)), Bach, L. (Chief Investigator (CI)), Gilfillan, C. (Chief Investigator (CI)), Lu, Z. X. (Chief Investigator (CI)), Reid, C. M. (Chief Investigator (CI)), Chen, G. (Chief Investigator (CI)) & Gwini, S. (Chief Investigator (CI))
1/07/19 → 30/06/23
Project: Research
-
Evaluation of primary aldosteronism testing in hypertensive patients with SLE in a tertiary hospital
Wong, M. (Leading Author), Hoi, A., Kent, J. R., Fuller, P., Yang, J. (Leading Author) & Vincent, F. B. (Leading Author), 2025, In: Lupus Science & Medicine. 12, 1, p. 1-3 3 p., e001524.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
A pilot study proposing an algorithm for pubertal induction in cerebral palsy
Trinh, A., Lim, A. S., Wong, P., Brown, J., Pitkin, J., Vollenhoven, B., Ebeling, P. R., Fuller, P. J., Milat, F. & Zacharin, M. R., Mar 2024, In: Journal of Pediatric Endocrinology and Metabolism. 37, 3, p. 222-227 6 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Captopril challenge test: an underutilized test in the diagnosis of primary aldosteronism
Jahan, S., Yang, J., Hu, J., Li, Q. & Fuller, P. J., Mar 2024, In: Endocrine Connections. 13, 3, 11 p., e230445.Research output: Contribution to journal › Review Article › Research › peer-review
Open Access3 Citations (Scopus) -
Diagnostic Delay and Disease Burden in Primary Aldosteronism: An International Patient Survey
Ananda, R. A., Gwini, S. M., Long, K. M., Lai, J. H., Chen, G., Russell, G. M., Stowasser, M., Fuller, P. J. & Yang, J., 1 Feb 2024, In: Hypertension. 81, 2, p. 348-360 13 p.Research output: Contribution to journal › Article › Research › peer-review
6 Citations (Scopus) -
Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: a systematic review and meta-analysis
Shah, S. S., Zhang, J., Gwini, S. M., Young, M. J., Fuller, P. J. & Yang, J., 2024, In: Journal of Human Hypertension. 38, 5, p. 383–392 10 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access13 Citations (Scopus)